Original Article
Nutritional index for immune-checkpoint inhibitor in patients with metastatic gastro-esophageal junction/gastric cancer
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2072-2081
.
(31 October 2022)
Glypican 1 promotes proliferation and migration in esophagogastric adenocarcinoma via activating AKT/GSK/β-catenin pathway
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2082-2104
.
(31 October 2022)
A randomized controlled trial of positive end-expiratory pressure on pulmonary oxygenation and biventricular function in esophageal cancer patients receiving one-lung ventilation under a lower FiO2
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2105-2114
.
(31 October 2022)
A bioinformatics analysis for diagnostic roles of the E2F family in esophageal cancer
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2115-2131
.
(31 October 2022)
Impact of caregiver burden on caregiver mental health in patients with esophageal cancer: chain mediating effects of benefit finding and rumination, a cross-sectional study
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2132-2143
.
(31 October 2022)
Artemisinin inhibits the development of esophageal cancer by targeting HIF-1α to reduce glycolysis levels
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2144-2153
.
(31 October 2022)
miR-375 suppresses the growth and metastasis of esophageal squamous cell carcinoma by targeting PRDX1
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2154-2168
.
(31 October 2022)
The clinical effect of conversion surgery for advanced gastric cancer patients with peritoneal metastasis
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2169-2177
.
(31 October 2022)
Prognostic risk factors for postoperative long-term outcomes in elderly stage IA gastric cancer patients
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2178-2185
.
(31 October 2022)
Cost-effectiveness of screening with polymerase chain reaction for Helicobacter pylori to prevent gastric cancer and peptic ulcers
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2186-2196
.
(31 October 2022)
Interfering HMGB3 release from cancer-associated fibroblasts by miR-200b represses chemoresistance and epithelial-mesenchymal transition of gastric cancer cells
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2197-2218
.
(31 October 2022)
Identification of a chemotherapy-associated gene signature for a risk model of prognosis in gastric adenocarcinoma through bioinformatics analysis
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2219-2233
.
(31 October 2022)
Identification of a five m6A-relevant mRNAs signature and risk score for the prognostication of gastric cancer
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2234-2248
.
(31 October 2022)
Modification of erythrocytes by internalizing Arg-Gly-Asp (iRGD) in boosting the curative effect of radiotherapy for gastric carcinoma
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2249-2258
.
(31 October 2022)
Analysis of blood markers for early colorectal cancer diagnosis
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2259-2268
.
(31 October 2022)
Development and validation of a nomogram based on neutrophil-to-lymphocyte ratio and fibrinogen-to-lymphocyte ratio for predicting recurrence of colorectal adenoma
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2269-2281
.
(31 October 2022)
A signature of Prevotella copri and Faecalibacterium prausnitzii depletion, and a link with bacterial glutamate degradation in the Kenyan colorectal cancer patients
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2282-2292
.
(31 October 2022)
Survival comparison of stage IIA rectal cancer with or without neoadjuvant therapy: a SEER database analysis with propensity score matching
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2293-2305
.
(31 October 2022)
Role of local therapy in the management of patients with metastatic anal squamous cell carcinoma: a National Cancer Database study
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2306-2321
.
(31 October 2022)
Regulation of survivin and caspase/Bcl-2/Cyto-C signaling by TDB-6 induces apoptosis of colorectal carcinoma LoVo cells
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2322-2332
.
(31 October 2022)
Effect of the systemic immune-inflammation index on postoperative complications and the long-term prognosis of patients with colorectal cancer: a retrospective cohort study
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2333-2339
.
(31 October 2022)
Nestin protein affects the maintenance of stem characteristics of colorectal cancer cells based on p53 dependent pathway
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2340-2350
.
(31 October 2022)
Complement C5 is a novel biomarker for liver metastasis of colorectal cancer
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2351-2365
.
(31 October 2022)
Locally advanced rectal mucinous adenocarcinoma: is preoperative radiation necessary?
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2366-2374
.
(31 October 2022)
Apparent diffusion coefficient is a good marker in predicting the prognosis in colorectal cancer liver metastases: a diagnostic study
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2375-2381
.
(31 October 2022)
Atractylenolide I inhibited the development of malignant colorectal cancer cells and enhanced oxaliplatin sensitivity through the PDK1-FoxO1 axis
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2382-2392
.
(31 October 2022)
Development and validation of a survival prediction model for 113,239 patients with colon cancer: a retrospective cohort study
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2393-2405
.
(31 October 2022)
Construction and assessment of a joint prediction model and nomogram for colorectal cancer
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2406-2414
.
(31 October 2022)
LINC00178 promotes cell growth, migration, and invasion in colorectal cancer in vitro and in vivo
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2415-2425
.
(31 October 2022)
Construction of a co-expression network and prediction of metastasis markers in colorectal cancer patients with liver metastasis
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2426-2438
.
(31 October 2022)
Circulating lncRNA EGFR-AS1 as a diagnostic biomarker of colorectal cancer and an indicator of tumor burden
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2439-2446
.
(31 October 2022)
TRPV3 inhibits colorectal cancer cell proliferation and migration by regulating the MAPK signaling pathway
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2447-2457
.
(31 October 2022)
STING promotes proliferation and induces drug resistance in colorectal cancer by regulating the AMPK-mTOR pathway
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2458-2471
.
(31 October 2022)
Collagen XV mediated the epithelial-mesenchymal transition to inhibit hepatocellular carcinoma metastasis
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2472-2484
.
(31 October 2022)
Estrogen receptor 1 inhibits the progression of hepatocellular carcinoma via positively regulating lncRNA maternally expressed gene 3 under high glucose conditions
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2485-2496
.
(31 October 2022)
Utility and specificity of plasma heat shock protein 90 alpha, CEA, and CA199 as the diagnostic test in colorectal cancer liver metastasis
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2497-2504
.
(31 October 2022)
Identification and validation in a novel quantification system of the glutamine metabolism patterns for the prediction of prognosis and therapy response in hepatocellular carcinoma
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2505-2521
.
(31 October 2022)
The value of contrast-enhanced ultrasound quantitative parameters in the prognosis prediction of hepatocellular carcinoma after thermal ablation: a retrospective cohort study
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2522-2531
.
(31 October 2022)
Clinical features of biliary tract cancer in Japanese individuals with Lynch syndrome
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2532-2538
.
(31 October 2022)
SGLT-2 as a potential target in pancreatic cancer: the preliminary clue from The Cancer Genome Atlas data
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2539-2552
.
(31 October 2022)
Construction and validation of a m6A RNA methylation and ferroptosis-related prognostic model for pancreatic cancer by integrated bioinformatics analysis
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2553-2564
.
(31 October 2022)
Review Article
Inflammatory bowel disease-associated malignancies and considerations for radiation impacting bowel: a scoping review
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2565-2582
.
(31 October 2022)
Challenges in the diagnosis of marginal zone lymphoma with symptoms of small intestinal disease: a case report and scoping review of the literature
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2583-2607
.
(31 October 2022)
Case Report
Long-term outcome of metachronous, multiple, early Epstein-Barr virus-associated gastric carcinoma: a case report
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2608-2614
.
(31 October 2022)
A fatal primary gastric melanoma treated by a double immunotherapy with ipilimumab/nivolumab: description of a case report
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2615-2619
.
(31 October 2022)
Progression of the tumor in a patient with a gastrointestinal stromal tumor with the PDGFRA exon 12 mutation who received multiple surgeries and multiple lines of tyrosine kinase inhibitor therapies: a case report
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2620-2625
.
(31 October 2022)
Abiraterone acetate for treatment of ectopic Cushing syndrome caused by ACTH-producing neuroendocrine tumor: a case report
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2626-2632
.
(31 October 2022)
Massive pancreatic serous cystadenomas raise important questions regarding surgical management of incidental pancreatic cystic lesions: a report of two cases
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2633-2638
.
(31 October 2022)
Conversion surgery by hand-assisted laparoscopic surgery following chemotherapy for rectal cancer with H3 liver metastases: a case report
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2639-2646
.
(31 October 2022)
Three-target treatment combined with surgery for BRAF V600E-mutant colon cancer with peritoneal metastasis: a case report
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2647-2653
.
(31 October 2022)
Anorectal manometry after rectal surgery: a case report with rectal bleeding and perforation
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2654-2659
.
(31 October 2022)
Preliminary experience of oral fruquintinib-capecitabine as a new maintenance treatment strategy for advanced colorectal cancer in the era of coronavirus disease 2019 (COVID-19): case report and literature review
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2660-2666
.
(31 October 2022)
Fruquintinib for refractory colorectal cancer in a pre-treated 82-year-old patient achieved a progression-free survival of 25 months: a case report
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2667-2671
.
(31 October 2022)
Anti-OJ antibody-positive anti-synthetase syndrome with repeated arthritis, fever, and recurrent liver cancer: a case report
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2672-2678
.
(31 October 2022)
iMDT Corner
Rectal gastrointestinal stromal tumor with metachronous liver metastasis demonstrated no relapse after multidisciplinary team discussion and comprehensive treatment: a case report
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2679-2688
.
(31 October 2022)
Letter to the Editor
Resection and thermal hepatic ablation of pancreatic neuroendocrine tumor liver metastases for prolonged survival
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2689-2690
.
(31 October 2022)
Platelet lymphocyte ratio and sarcopenia were associated with survival after hepatocellular carcinoma undergoing curative resection
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2691-2692
.
(31 October 2022)
Radiofrequency ablation has similar short-term effects but significantly lowers the long-term effect compared with routine resection in the treatment of small hepatocellular carcinoma
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2693-2695
.
(31 October 2022)
Liver transplantation for cholangiocarcinoma: exploring a new land
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2696-2698
.
(31 October 2022)
Excellent clinical outcomes can be achieved with neoadjuvant chemoradiation and orthotopic liver transplantation for unresectable cholangiocarcinoma: support for the need of an international transplant protocol
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2699-2700
.
(31 October 2022)
Is D2 laparoscopic gastrectomy essential for elderly patients with advanced gastric cancer?—reply letter
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2701-2702
.
(31 October 2022)
Is D2 laparoscopic gastrectomy essential for elderly patients with advanced gastric cancer?
Journal of Gastrointestinal Oncology
2022;
13
(5)
:2703-2704
.
(31 October 2022)
